Direxion Shares ETF Trust (PILL)
管理公司 · ARCX · 系列 S000050532 · 在 SEC EDGAR 上查看 ↗
- 净资产
- $12.9M
- 持仓
- 65
- 截至
- 2026年4月30日 陈旧
- 前十大持仓权重
- 40.83%
- 有效持仓数量
- 19.8
- 持仓高于 1%
- 50
本页内容
基金流向（SEC报告）
- 上个月（四月 2026）
- -$557K
- 截至四月 2026的季度
- -$5.8M
- 过去12个月
- -$9.4M
五月 2025 – 四月 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
完整构成 65 持仓
| 名称 | CUSIP | 价值 | % | 余额 | 类别 | 国家 |
|---|---|---|---|---|---|---|
| GOLDMAN FINANCIAL | — | $2.4M | 18.99 | 2448306 | STIV | US |
| 未知证券 | — | $660K | 5.12 | 1 | DE | US |
| DREYFUS GOVERNMENT CASH MANAGE | — | $483K | 3.75 | 483278 | STIV | US |
| ORGANON & COMPANY | 68622V106 | $357K | 2.77 | 26958 | EC | US |
| CORCEPT THERAPEUTICS INC | 218352102 | $238K | 1.85 | 5114 | EC | US |
| ENLIVEN THERAPEUTICS INC | 29337E102 | $232K | 1.80 | 5620 | EC | US |
| AXSOME THERAPEUTICS INC | 05464T104 | $225K | 1.74 | 1081 | EC | US |
| OMEROS CORP | 682143102 | $211K | 1.64 | 14463 | EC | US |
| PERRIGO COMPANY PLC | G97822103 | $208K | 1.62 | 17588 | EC | IE |
| DEFINIUM THERAPEUTICS INC | 24477V105 | $203K | 1.57 | 9260 | EC | CA |
| NEKTAR THERAPEUTICS | 640268306 | $200K | 1.55 | 2353 | EC | US |
| TREVI THERAPEUTICS INC | 89532M101 | $199K | 1.54 | 14451 | EC | US |
| TERNS PHARMACEUTICALS INC | 880881107 | $195K | 1.51 | 3689 | EC | US |
| INDIVIOR PHARMACEUTICALS INC | 45579U109 | $193K | 1.50 | 5257 | EC | US |
| PACIRA BIOSCIENCES INC | 695127100 | $193K | 1.49 | 7557 | EC | US |
| HARROW INC | 415858109 | $189K | 1.47 | 4670 | EC | US |
| JAZZ PHARMACEUTICALS PLC | G50871105 | $189K | 1.47 | 931 | EC | IE |
| HARMONY BIOSCIENCES HOLDINGS INC | 413197104 | $187K | 1.45 | 5993 | EC | US |
| ROYALTY PHARMA PLC | G7709Q104 | $185K | 1.44 | 3695 | EC | GB |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | $185K | 1.43 | 11556 | EC | US |
| VIATRIS INC | 92556V106 | $185K | 1.43 | 12352 | EC | US |
| CRINETICS PHARMACEUTICALS INC | 22663K107 | $181K | 1.40 | 4666 | EC | US |
| ANI PHARMACEUTICALS INC | 00182C103 | $180K | 1.39 | 2262 | EC | US |
| LIGAND PHARMACEUTICALS INC | 53220K504 | $179K | 1.39 | 780 | EC | US |
| MBX BIOSCIENCES INC | 55287L101 | $177K | 1.37 | 5866 | EC | US |
| INNOVIVA INC | 45781M101 | $177K | 1.37 | 7695 | EC | US |
| LIQUIDIA CORP | 53635D202 | $175K | 1.36 | 4474 | EC | US |
| AMNEAL PHARMACEUTICALS INC | 03168L105 | $175K | 1.36 | 13575 | EC | US |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | $175K | 1.35 | 28515 | EC | US |
| BRISTOL-MYERS SQUIBB COMPANY | 110122108 | $174K | 1.35 | 2876 | EC | US |
| EDGEWISE THERAPEUTICS INC | 28036F105 | $172K | 1.34 | 5567 | EC | US |
| OCULAR THERAPEUTIX INC | 67576A100 | $170K | 1.32 | 18162 | EC | US |
| PFIZER INC | 717081103 | $169K | 1.31 | 6321 | EC | US |
| NUVATION BIO INC | 67080N101 | $167K | 1.30 | 37591 | EC | US |
| ZOETIS INC | 98978V103 | $166K | 1.28 | 1441 | EC | US |
| ELANCO ANIMAL HEALTH INC | 28414H103 | $165K | 1.28 | 7357 | EC | US |
| COLLEGIUM PHARMACEUTICAL INC | 19459J104 | $163K | 1.27 | 4844 | EC | US |
| JOHNSON & JOHNSON | 478160104 | $163K | 1.27 | 710 | EC | US |
| MERCK & COMPANY INC | 58933Y105 | $162K | 1.26 | 1485 | EC | US |
| ALUMIS INC | 022307102 | $162K | 1.25 | 6551 | EC | US |
| ELI LILLY & COMPANY | 532457108 | $161K | 1.25 | 172 | EC | US |
| TARSUS PHARMACEUTICALS INC | 87650L103 | $157K | 1.22 | 2469 | EC | US |
| SUPERNUS PHARMACEUTICALS INC | 868459108 | $156K | 1.21 | 3242 | EC | US |
| PHIBRO ANIMAL HEALTH CORP | 71742Q106 | $155K | 1.20 | 2911 | EC | US |
| EYEPOINT INC | 30233G209 | $153K | 1.18 | 11564 | EC | US |
| PRESTIGE CONSUMER HEALTHCARE INC | 74112D101 | $150K | 1.16 | 2662 | EC | US |
| AMPHASTAR PHARMACEUTICALS INC | 03209R103 | $146K | 1.13 | 6654 | EC | US |
| THERAVANCE BIOPHARMA INC | G8807B106 | $132K | 1.02 | 7856 | EC | KY |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | $131K | 1.01 | 11659 | EC | US |
| RAPPORT THERAPEUTICS INC | 75383L102 | $130K | 1.01 | 3931 | EC | US |
页 1
/ 2
← 上一页
下一页 →
行业细分
Healthcare
70.5%
其他/未映射
29.5%
机构持有人 (13F) 8 家申报者
在其季度SEC表格13F中报告持有该ETF的机构。仅限多头头寸；单个申报者可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
| 机构 | 价值 | % 已追踪的13F | 股份 | 类型 | 截至 |
|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1348938 | 69.77% | 74692 | 股份 | 2026年6月30日 |
| GTS SECURITIES LLC | $458543 | 23.72% | 25390 | 股份 | 2026年6月30日 |
| Tower Research Capital LLC (TRC) | $105163 | 5.44% | 5823 | 股份 | 2026年6月30日 |
| UBS Group AG | $18385 | 0.95% | 1018 | 股份 | 2026年6月30日 |
| FINANCIAL CONSULATE, INC | $1806 | 0.09% | 100 | 股份 | 2026年6月30日 |
| SIMPLEX TRADING, LLC | $397 | 0.02% | 22 | 股份 | 2026年6月30日 |
| MORGAN STANLEY | $38 | 0.00% | 2 | 股份 | 2026年6月30日 |
| AlphaMark Advisors, LLC | $7 | 0.00% | 1000 | 股份 | 2024年12月31日 |
同类基金
来自该发行方的更多信息
| 基金 | 资产管理规模 |
|---|---|
| SOXL Direxion Shares ETF Trust | $16.9B |
| SPXL Direxion Shares ETF Trust | $5.9B |
| TSLL Direxion Shares ETF Trust | $5.0B |
| TECL Direxion Shares ETF Trust | $4.7B |
| TMF Direxion Shares ETF Trust | $2.7B |
| FAS Direxion Shares ETF Trust | $2.0B |
| SOXS Direxion Shares ETF Trust | $1.9B |
| KORU Direxion Shares ETF Trust | $1.6B |
| TNA Direxion Shares ETF Trust | $1.5B |
| MUU Direxion Shares ETF Trust | $1.4B |
规模相似
| 基金 | 资产管理规模 |
|---|---|
| MPLY Strategy Shares | $13.2M |
| EEMO Invesco Exchange-Traded Fund ... | $13.2M |
| SZNE Pacer Funds Trust | $13.4M |
| SNPG DBX ETF Trust | $13.4M |
| UXJA First Trust Exchange-Traded F... | $13.5M |
| SDCP Virtus ETF Trust II | $12.8M |
| EMIF iShares Trust | $12.8M |
| FARX Advisors' Inner Circle Fund II | $12.8M |
| EQLT iShares Trust | $12.7M |
| TYLG Global X Funds | $12.7M |